Free Trial

14,697 Shares in Lemonade, Inc. (NYSE:LMND) Purchased by ProShare Advisors LLC

Lemonade logo with Finance background

ProShare Advisors LLC purchased a new position in Lemonade, Inc. (NYSE:LMND - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 14,697 shares of the company's stock, valued at approximately $539,000.

Other hedge funds have also made changes to their positions in the company. Quarry LP raised its stake in Lemonade by 300.4% during the 4th quarter. Quarry LP now owns 933 shares of the company's stock valued at $34,000 after acquiring an additional 700 shares in the last quarter. Avior Wealth Management LLC bought a new position in shares of Lemonade in the fourth quarter valued at approximately $40,000. Russell Investments Group Ltd. increased its stake in shares of Lemonade by 318.8% during the fourth quarter. Russell Investments Group Ltd. now owns 1,139 shares of the company's stock valued at $42,000 after acquiring an additional 867 shares during the period. BNP Paribas bought a new stake in Lemonade during the fourth quarter worth approximately $57,000. Finally, PNC Financial Services Group Inc. lifted its position in Lemonade by 116.8% in the fourth quarter. PNC Financial Services Group Inc. now owns 1,596 shares of the company's stock worth $59,000 after purchasing an additional 860 shares during the period. Institutional investors own 80.30% of the company's stock.

Insider Buying and Selling at Lemonade

In other Lemonade news, major shareholder Softbank Group Capital Ltd sold 422,177 shares of the business's stock in a transaction dated Friday, May 2nd. The stock was sold at an average price of $30.17, for a total value of $12,737,080.09. Following the completion of the sale, the insider now owns 10,015,984 shares of the company's stock, valued at $302,182,237.28. The trade was a 4.04% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider John Sheldon Peters sold 1,899 shares of the business's stock in a transaction dated Tuesday, March 4th. The stock was sold at an average price of $33.79, for a total value of $64,167.21. Following the completion of the sale, the insider now directly owns 87,609 shares of the company's stock, valued at $2,960,308.11. This represents a 2.12% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 2,744,890 shares of company stock worth $87,413,986 over the last 90 days. 14.70% of the stock is currently owned by corporate insiders.

Lemonade Stock Performance

Shares of LMND stock traded down $0.65 on Wednesday, reaching $32.47. 1,681,237 shares of the company's stock traded hands, compared to its average volume of 1,932,564. Lemonade, Inc. has a 12-month low of $14.03 and a 12-month high of $53.85. The company has a market capitalization of $2.38 billion, a P/E ratio of -10.68 and a beta of 2.13. The business's 50 day moving average price is $30.10 and its two-hundred day moving average price is $34.95.

Lemonade (NYSE:LMND - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported ($0.86) earnings per share for the quarter, missing analysts' consensus estimates of ($0.84) by ($0.02). Lemonade had a negative net margin of 43.51% and a negative return on equity of 32.85%. During the same period in the previous year, the company posted ($0.67) EPS. Lemonade's revenue was up 27.0% on a year-over-year basis. Research analysts predict that Lemonade, Inc. will post -3.03 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the company. Morgan Stanley cut Lemonade from an "equal weight" rating to an "underweight" rating and lowered their price target for the company from $35.00 to $24.00 in a research report on Tuesday, April 8th. Piper Sandler dropped their price target on shares of Lemonade from $44.00 to $34.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 26th. Finally, Keefe, Bruyette & Woods dropped their price target on shares of Lemonade from $25.00 to $22.00 and set an "underperform" rating on the stock in a research report on Tuesday, April 22nd. Four equities research analysts have rated the stock with a sell rating, one has given a hold rating and one has assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $28.17.

Get Our Latest Report on LMND

Lemonade Company Profile

(Free Report)

Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.

Featured Stories

Institutional Ownership by Quarter for Lemonade (NYSE:LMND)

Should You Invest $1,000 in Lemonade Right Now?

Before you consider Lemonade, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lemonade wasn't on the list.

While Lemonade currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings Preview: HUGE Stock Move Ahead
These 5 Small Stocks Could Deliver Huge Returns
ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines